These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 19329549

  • 21. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.
    Yamada K, Ohnishi T, Hashimoto K, Ohba H, Iwayama-Shigeno Y, Toyoshima M, Okuno A, Takao H, Toyota T, Minabe Y, Nakamura K, Shimizu E, Itokawa M, Mori N, Iyo M, Yoshikawa T.
    Biol Psychiatry; 2005 Jun 15; 57(12):1493-503. PubMed ID: 15953485
    [Abstract] [Full Text] [Related]

  • 22. Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development.
    Wang LZ, Zhu XZ.
    Acta Pharmacol Sin; 2003 Oct 15; 24(10):965-74. PubMed ID: 14531937
    [Abstract] [Full Text] [Related]

  • 23. Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications for schizophrenia.
    Almond SL, Fradley RL, Armstrong EJ, Heavens RB, Rutter AR, Newman RJ, Chiu CS, Konno R, Hutson PH, Brandon NJ.
    Mol Cell Neurosci; 2006 Aug 15; 32(4):324-34. PubMed ID: 16843004
    [Abstract] [Full Text] [Related]

  • 24. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
    Ferraris DV, Tsukamoto T.
    Curr Pharm Des; 2011 Aug 15; 17(2):103-11. PubMed ID: 21361869
    [Abstract] [Full Text] [Related]

  • 25. Comparative characterization of three D-aspartate oxidases and one D-amino acid oxidase from Caenorhabditis elegans.
    Katane M, Saitoh Y, Seida Y, Sekine M, Furuchi T, Homma H.
    Chem Biodivers; 2010 Jun 15; 7(6):1424-34. PubMed ID: 20564561
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Determination of D-serine and D-alanine in the tissues and physiological fluids of mice with various D-amino-acid oxidase activities using two-dimensional high-performance liquid chromatography with fluorescence detection.
    Miyoshi Y, Hamase K, Tojo Y, Mita M, Konno R, Zaitsu K.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug 15; 877(24):2506-12. PubMed ID: 19586804
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
    Smith SM, Uslaner JM, Yao L, Mullins CM, Surles NO, Huszar SL, McNaughton CH, Pascarella DM, Kandebo M, Hinchliffe RM, Sparey T, Brandon NJ, Jones B, Venkatraman S, Young MB, Sachs N, Jacobson MA, Hutson PH.
    J Pharmacol Exp Ther; 2009 Mar 15; 328(3):921-30. PubMed ID: 19088300
    [Abstract] [Full Text] [Related]

  • 31. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
    Yang CR, Svensson KA.
    Pharmacol Ther; 2008 Dec 15; 120(3):317-32. PubMed ID: 18805436
    [Abstract] [Full Text] [Related]

  • 32. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide.
    Fang J, Sawa T, Akaike T, Maeda H.
    Cancer Res; 2002 Jun 01; 62(11):3138-43. PubMed ID: 12036926
    [Abstract] [Full Text] [Related]

  • 33. Spinal D-amino acid oxidase contributes to neuropathic pain in rats.
    Zhao WJ, Gao ZY, Wei H, Nie HZ, Zhao Q, Zhou XJ, Wang YX.
    J Pharmacol Exp Ther; 2010 Jan 01; 332(1):248-54. PubMed ID: 19828879
    [Abstract] [Full Text] [Related]

  • 34. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun 01; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The antiviral drug acyclovir is a slow-binding inhibitor of (D)-amino acid oxidase.
    Katane M, Matsuda S, Saitoh Y, Sekine M, Furuchi T, Koyama N, Nakagome I, Tomoda H, Hirono S, Homma H.
    Biochemistry; 2013 Aug 20; 52(33):5665-74. PubMed ID: 23859606
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
    Konradsson A, Marcus MM, Hertel P, Svensson TH, Jardemark KE.
    Synapse; 2006 Aug 20; 60(2):102-8. PubMed ID: 16715496
    [Abstract] [Full Text] [Related]

  • 39. Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis.
    Kawazoe T, Tsuge H, Imagawa T, Aki K, Kuramitsu S, Fukui K.
    Biochem Biophys Res Commun; 2007 Apr 06; 355(2):385-91. PubMed ID: 17303072
    [Abstract] [Full Text] [Related]

  • 40. Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
    Wang D, Noda Y, Zhou Y, Nitta A, Furukawa H, Nabeshima T.
    Neuropharmacology; 2007 Mar 06; 52(4):1179-87. PubMed ID: 17313962
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.